The Supreme Court of India has stepped in to address a critical gap in healthcare delivery for patients suffering from Spinal Muscular Atrophy (SMA), initiating suo motu proceedings to examine the lack of adequate and systematic treatment infrastructure. A bench comprising Chief Justice of India Surya Kant, Justice Joymalya Bagchi, and Justice V. Mohana registered the case titled 'In Re: Lack of Adequate and Systematic Treatment for SMA Patients and Other Ancillary Issues', signalling the court's recognition that financial constraints and organisational failures are preventing both preventive care and post-treatment rehabilitation for affected individuals.
Spinal Muscular Atrophy is a rare genetic disorder that causes progressive weakness and wasting of muscles. The condition affects motor neurons, leading to loss of muscle function and, in severe cases, respiratory complications. Patients require ongoing medical intervention, physiotherapy, mobility aids, and psychological support—interventions that remain largely inaccessible to most affected families due to cost and limited institutional capacity. The bench's decision to examine this issue demonstrates judicial concern that the existing healthcare system has failed to create systematic pathways for SMA patient care at the national level.
The court's observations centred on a fundamental problem: inadequate financial support hinders both preventive measures and post-atrophy treatment. This dual-pronged failure means that patients do not receive early diagnostic support or intervention, and once the disease progresses, they lack access to rehabilitation and management services. The bench recognised that this is not merely an individual hardship but a systemic gap requiring coordinated state and central action.
Dedicated Corpus and Permanent Funding Mechanism
In response to these findings, the bench mooted the creation of a dedicated fund or corpus to provide financial assistance specifically for SMA patients. The proposal goes beyond ad-hoc relief measures or existing general disability schemes, which have proven insufficient to address the specialised and often expensive needs of SMA care. The court called for a comprehensive proposal outlining how such a corpus would be generated, managed, and distributed.
The bench emphasised the need for a regular and permanent mechanism for contributions and fund maintenance. This language signals that the court views the problem as requiring sustained, predictable funding rather than one-time allocations. A permanent mechanism would allow healthcare providers, rehabilitation centres, and patient support organisations to plan services with confidence that resources would be available year after year.
The bench did not specify the exact amount or the sources from which the corpus should be funded, leaving these details to be worked out through the ongoing proceedings. However, the emphasis on a "regular and permanent mechanism" suggests the court expects the Union and State governments to commit budgetary resources, potentially supplemented by corporate social responsibility contributions or philanthropic funding. The proposal also implies that the corpus should be independently managed, possibly through a dedicated board or trust, to ensure transparency and efficient allocation.
Systemic Gaps in Patient Care Infrastructure
The suo motu proceedings come at a time when India's healthcare system faces mounting pressure to address rare and genetic diseases. SMA patients often struggle to access diagnosis, specialist consultation, and evidence-based treatment. Many families are unaware of available therapies or support services, while others cannot afford them. Rehabilitation centres equipped to handle SMA cases are concentrated in metropolitan areas, leaving vast rural and semi-urban populations without access to appropriate care.
The court's intervention reflects broader judicial recognition of healthcare as a fundamental right. Previous Supreme Court judgments have established that the state has a duty to ensure access to essential medical services. SMA, though rare, represents a category of disease where individual patients face catastrophic costs and where the state's failure to intervene creates a clear violation of this duty.
The bench's decision to frame the issue as one requiring systematic treatment, not merely individual cases, suggests the court intends to examine the role of medical colleges, government hospitals, and private healthcare providers in building SMA care capacity. This may include questions about training specialists in SMA management, establishing diagnostic protocols, and creating referral networks.
Parallel Proceedings on Rehabilitation Standards
On October 8, 2026, the same bench also sought state-wise compliance reports regarding the regulation, registration, and standards of rehabilitation centres, child development centres, and mental health establishments catering to children with disabilities. This directive emerged from a Public Interest Litigation titled 'Rahul Bajaj v. Union of India & Ors.', which highlighted gaps in implementing statutory safeguards for disabled children receiving rehabilitation and mental health services. The bench directed the Centre to coordinate with all States and Union Territories to collect and submit compliance reports via affidavits.
These parallel proceedings are interconnected. SMA patients, particularly children, require access to properly regulated and well-equipped rehabilitation facilities. The court's demand for compliance reports on rehabilitation standards directly supports its suo motu proceedings on SMA treatment gaps. By examining both the funding mechanisms and the institutional infrastructure, the bench is constructing an integrated approach to address the problem from multiple angles.
Next Steps and Judicial Timeline
The suo motu proceedings initiated by the bench indicate that the court expects substantive responses from the Union and State governments. The bench will likely issue directions requiring the Centre to prepare a detailed proposal for the dedicated corpus, including funding mechanisms, governance structure, eligibility criteria for beneficiaries, and timelines for implementation.
The next hearing on the parallel PIL concerning rehabilitation centre standards is scheduled for October 22, 2026. This timeline suggests the court intends to move expeditiously on these matters, recognising the urgency of patient needs. SMA patients cannot afford prolonged judicial processes; every year of delay means further disease progression and lost opportunities for intervention.
The court may seek input from medical experts, patient advocacy groups, and state health departments. Such consultation would ensure that the proposed corpus and treatment framework are grounded in clinical reality and implementable within existing healthcare structures. The bench may direct the appointment of a committee or commission to study the issue in depth and submit recommendations.
Healthcare Policy and Disability Rights
The suo motu proceedings signal that the Supreme Court is willing to intervene directly in healthcare policy when systemic failures affect vulnerable populations. This approach differs from the traditional model where courts respond only to petitions filed by affected parties. By initiating proceedings on its own motion, the bench acknowledges that SMA patients, often economically disadvantaged and geographically dispersed, may lack the resources or awareness to approach the court themselves.
The emphasis on a dedicated corpus also suggests the court views disease-specific funding as preferable to relying on general health budgets, which are often stretched thin. This model, if successful for SMA, could serve as a template for addressing other rare genetic and chronic diseases where patients face similar barriers to care.
For state governments and the Union, the proceedings create an obligation to engage constructively with the court's concerns. States cannot simply claim budgetary constraints or lack of institutional capacity as excuses for inaction. The court will expect concrete proposals demonstrating how each state intends to improve SMA patient access to diagnosis, treatment, and rehabilitation.
The bench's decision to couple the SMA proceedings with demands for compliance on rehabilitation centre standards indicates that the court views these issues as part of a broader disability rights and healthcare access agenda. This approach recognises that improving care for SMA patients requires not just money but also institutional reform, regulatory oversight, and accountability from healthcare providers.
As the proceedings unfold, the bench will likely issue interim orders directing immediate relief measures while longer-term solutions are developed. These could include directions to state health authorities to identify and register SMA patients, establish diagnostic centres, and create care pathways. The court may also direct that patients receive subsidised or free access to available therapies pending the establishment of the dedicated corpus.
For the first time, the highest court has recognised SMA patients' plight as a matter of national concern requiring systematic judicial and administrative response. The success of these proceedings will depend on the willingness of governments to commit resources and the court's capacity to monitor compliance with its orders over time.
Comments
Sign in to read the discussion and share your thoughts.